-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NvK6JaJJh2u0AhKqEOZcHO5dFcjIah1eNHTwf/lhGgzBACejIajbNdNdTKGWdz1b JOhSZmZhAu9ihzsgq8P0Wg== 0000000000-05-056514.txt : 20060320 0000000000-05-056514.hdr.sgml : 20060320 20051107143428 ACCESSION NUMBER: 0000000000-05-056514 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051107 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 PUBLIC REFERENCE ACCESSION NUMBER: 0001047469-04-032417 LETTER 1 filename1.txt Mail Stop 0309 February 10, 2005 Mr. Joshua S. Boger Chief Executive Officer Vertex Pharmaceuticals Incorporated 130 Waverly Street Cambridge, Massachusetts 02139-4242 Re: Vertex Pharmaceuticals Incorporated Amendment No. 1 Registration Statement on Form S-3 filed January 19, 2005 File No. 333-120055 Dear Mr. Boger: We have limited our review of the above referenced filing to only the matters addressed herein. Please understand that the purpose of our review process is to assist you in your compliance with the applicable disclosure requirements and to enhance the overall disclosure in your filing. We look forward to working with you in these respects. We welcome any questions you may have about our comments or on any other aspect of our review. Feel free to call us at the telephone numbers listed at the end of this letter. 1. We note your response to our prior comment 1. Please revise your disclosure to indicate which selling stockholders are broker- dealers and which are only affiliates of broker-dealers. In particular, we refer to your disclosure in footnote 3 to the selling security holder table. It should be clear from your disclosure who is a broker- dealer and who is an affiliate of a broker-dealer. We will consider a written request for acceleration of the effective date of the registration statement as a confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the securities specified in the above registration statement. We will act on the request and, pursuant to delegated authority, grant acceleration of the effective date. We direct your attention to Rules 460 and 461 regarding requesting acceleration of a registration statement. Please allow adequate time after the filing of any amendment for further review before submitting a request for acceleration. Please provide this request at least two business days in advance of the requested effective date. Please direct any questions to Sonia Barros at (202) 824-5304 or Suzanne Hayes at (202) 942-1789. Sincerely, Jeffrey Riedler Assistant Director cc: Michael L. Fantozzi, Esq. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC One Financial Center Boston, MA 02111 ?? ?? ?? ?? Mr. Joshua S. Boger February 10, 2005 Page 1 -----END PRIVACY-ENHANCED MESSAGE-----